Table 2 —

Demographic data, baseline and outcome measures for subjects assigned to the CHOx and low-GI diet groups

VariableStudy diet
PStudy diet
P*
CHOx (n = 49)Low GI (n = 55)CHOx (n = 38)Low GI (n = 51)
Demographic data:
 Sex (% male)51490.84
 Age (years)10.2 ± 1.610.7 ± 1.60.11
 Duration of diabetes (years)4.0 (1.1–9.9)3.4 (1.3–12.2)0.83
 Parents’ marital status (% married)84890.69
 Socioeconomic status§
  Father’s occupation4.2 (2.3–6.5)4.1 (1.5–6.6)0.89
  Mother’s occupation5.3 (3.6–6.66)5.3 (2.3–6.4)0.10
Baseline values
12 Months
Clinical measures:
 HbA1c (%)8.6 ± 1.48.3 ± 1.30.128.6 ± 1.48.0 ± 1.00.05
 Insulin dose (U/kg)0.9 ± 0.31.0 ± 0.30.151.0 ± 0.31.1 ± 0.30.87
 Insulin injection regimen (% on two injections per day)98950.6298910.21
 Episodes of hyperglycemia (mean number per month)14.8 ± 11.211.7 ± 9.40.081l6.8 ± 11.811.2 ± 9.80.06
 Episodes of hypoglycemia (mean number per month)7.3 ± 5.76.9 ± 6.20.735.8 ± 5.56.9 ± 6.80.37
  • Data are mean ± SD or %.

  • *

    * P using multiple linear regression adjusting for the appropriate baseline measure;

  • P using Pearson’s χ2 analysis or Fisher’s exact test where appropriate;

  • P using Wilcoxon’s rank-sum test without adjustment for baseline measure;

  • §

    § Daniel’s Prestige Scale, reported as median (range), P using Wilcoxon’s rank-sum test.